A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Atezolizumab|DRUG: Ipatasertib|DRUG: SGN-LIV1A|DRUG: Bevacizumab|DRUG: Chemotherapy (Gemcitabine + Carboplatin or Eribulin)|DRUG: Selicrelumab|DRUG: Tocilizumab|DRUG: Nab-Paclitaxel|DRUG: Sacituzumab Govitecan|DRUG: Abemaciclib|DRUG: Fulvestrant|DRUG: Ribociclib|DRUG: Inavolisib|DRUG: Inavolisib (9 mg)|DRUG: Inavolisib (6 mg)|DRUG: Trastuzumab Deruxtecan
Sponsor: Hoffmann-La Roche
Collaborators: Seagen Inc.|Gilead Sciences